Study shows baby helmets yield high success rate

Many infants need cranial remolding orthoses to assist in reshaping their heads. Research shows they have a high success rate with infants

5:00 AM

Author | Valerie Goodwin

mother baby helmet head shape
Jacob Dwyer, Michigan Medicine

On average, about 450 infants are fit with a cranial remolding orthosis, also known as a helmet, each year at the University of Michigan Orthotics and Prosthetics Center.

These helmets help to reshape an infant’s irregular skull.

Research from the University of Michigan Orthotics and Prosthetics Center looked at the effectiveness of the Michigan Cranial Reshaping Helmet and what age it was best to prescribe them at.

Research published in the Journal of Prosthetics and Orthotics focused on the success rates of cranial helmets in 300 infants with positional plagiocephaly, a skull deformity in which the skull is asymmetric; it’s flattened on one side in the back and on the other side in the front.

Each of the infants was prescribed a helmet to help shape their skull into a symmetrical shape as they grew.

“The helmets allowed the flattened areas of the head to grow until they matched the rounded areas,” said Hannah Gensch, resident orthotist, as well as a researcher under Jennifer Richards, MA, CPO, lead author on the study.

“We measured the largest diagonal diameter of the head from the forehead to the back of the skull to determine the size of the helmet. The helmet stops the growth of the largest part of the skull and allows room for the rest of the skull to grow to that size, so the child ends up with a symmetric oval shape.”

Study results showed the chances of achieving a symmetric head shape were significantly greater when the infant’s deformity was moderate, as opposed to when it was severe, and the chances of achieving a symmetric head shape were somewhat greater when the helmet was provided at less than six months old, as opposed to older.

“Due to the malleability of infants’ skulls, prescribing a helmet before six months of age increased the chances of achieving a symmetric head shape,” said Gensch.

“If the infant had a severe deformity or was prescribed the helmet later in infancy, the chance the infant would reach a fully symmetric head shape was decreased. However, it was still common to see at least a 50% improvement in head shape.”

Gensch states that there are no medical concerns if the skull does not reach a symmetric shape.

“Helmets are mostly for cosmetic purposes,” said Gensch. “In the most severe cases, not treating an infant with an asymmetric skull with a helmet could lead to jaw issues or increased orthodontic needs in the future, but this is rare.”

If you notice an asymmetric head shape in your infant or think that a helmet might be beneficial, talk to your pediatrician to learn more.

Additional authors include Chelsea A. Richards, MPO, CO; Alyssa M. Petz, MPO, CO; Claire E. Vallery, MPO, CO; and Jennifer A. Richards, MA, CPO, from the University of Michigan Orthotics and Prosthetics Center, University of Michigan, Ann Arbor, Michigan. Matheos Yosef, PhD; and Shokoufeh H. Khalatbari, MS, from the Michigan Institute for Clinical and Health Research, University of Michigan, Ann Arbor, Michigan. Christopher J. Frank, MD, PhD, from the Department of Family Medicine as well as the Institution for Health Care Policy and Innovation at the University of Michigan, Ann Arbor, Michigan.

Paper: “Success Rates of Cranial Remolding Orthosis Treatment of Plagiocephaly based on Initial Presentation,” Journal of Prosthetics and Orthotics. DOI: 10.1097/JPO.0000000000000481


More Articles About:

Basic Science and Laboratory Research Orthotics Neurology Children's Health prosthetics
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Health Lab

4 ways to teach your teen safe driving habits

New motorists cause a disproportionate number of distracted driving accidents. That’s why laying the groundwork for safe habits must begin before your teen gets the keys.
Portrait of Peter Mourani, M.D., Professor and Associate Chair of Research for the Department of Pediatrics and Division Director of Pediatric Critical Care Medicine at Michigan Medicine and U-M Health C.S. Mott Children's Hospital.
News Release

U-M-led consortium to receive up to $52 million in NIH funding to study why viral respiratory infections affect children differently

A Michigan Medicine-led research consortium has secured approval for up to $52 million in federal funding to launch a multicenter study examining why some young children recover fully from viral lower respiratory tract infections while others develop severe illness or lasting problems such as asthma.
Purple shaded illustration of doctor listening to heart of patient on a bed
Health Lab

The AI is listening: Implications of machine generated clinical notes on health care

Michigan Medicine experts argue that use of artificial intelligent scribes during health care visits should be more carefully examined .
Cole, wearing sunglasses and a purple Calming the Storm t-shirt with a rainbow, is seated on a blanket outdoors and holding a Mott teddy bear.
Philanthropy News

A pediatric epilepsy fundraiser that changes lives

Your support of Calming the Storm advances pediatric epilepsy research and patient care programs. There are many ways you can contribute to make a difference for so many children and families.
Father comforts sick child
News Release

15 years of data will help uncover how flu spreads—and how to reduce its impact

$14.2-million NIH award to University of Michigan funds research to untangle intricacies of person-to-person flu transmission—and reduce illness, deaths, economic losses
Michelle Hastings, Ph.D. and lab member look at molecule on computer screen.
News Release

$3.9 million NIH grant to fuel U-M effort to develop first targeted therapy for fatal childhood brain disorder

A team led by Dr. Michelle Hastings will advance a new RNA-based medicine for the most common form of CLN3 Batten disease toward clinical trials